Author

Chris Bakal

Primary ORCID profile (0000-0002-0413-6744 · 13 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Chris BakaliD13 papers · Institute of Cancer Research

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Chloe M. SimpsoniD· 1 shared Fernando Calvo· 1 shared Nicola Ferrari· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chloe M. SimpsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The dynamics of ERK signaling in melanoma, and the response to BRAF or MEK inhibition, are cell cycle dependent.

Chloe M. Simpson, Nicola Ferrari, Fernando Calvo, Chris Bakal

This study shows ERK signaling in melanoma is cell cycle dependent, with distinct responses to BRAF or MEK inhibition before and after passing the restriction point.

bioRxiv · Aug 13, 2018 · PreprintCancer Biology